146 related articles for article (PubMed ID: 37752418)
21. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.
Liu WH; Yeh SH; Lu CC; Yu SL; Chen HY; Lin CY; Chen DS; Chen PJ
Gastroenterology; 2009 Feb; 136(2):683-93. PubMed ID: 19027010
[TBL] [Abstract][Full Text] [Related]
22. Gender disparity of hepatocellular carcinoma: the roles of sex hormones.
Yeh SH; Chen PJ
Oncology; 2010 Jul; 78 Suppl 1():172-9. PubMed ID: 20616601
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-212 suppresses tumor growth of human hepatocellular carcinoma by targeting FOXA1.
Dou C; Wang Y; Li C; Liu Z; Jia Y; Li Q; Yang W; Yao Y; Liu Q; Tu K
Oncotarget; 2015 May; 6(15):13216-28. PubMed ID: 25965836
[TBL] [Abstract][Full Text] [Related]
24. ABL1, Overexpressed in Hepatocellular Carcinomas, Regulates Expression of NOTCH1 and Promotes Development of Liver Tumors in Mice.
Wang F; Hou W; Chitsike L; Xu Y; Bettler C; Perera A; Bank T; Cotler SJ; Dhanarajan A; Denning MF; Ding X; Breslin P; Qiang W; Li J; Koleske AJ; Qiu W
Gastroenterology; 2020 Jul; 159(1):289-305.e16. PubMed ID: 32171747
[TBL] [Abstract][Full Text] [Related]
25. Elevated FOXA1 Expression Indicates Poor Prognosis in Liver Cancer due to Its Effects on Cell Proliferation and Metastasis.
Liu Z; Wang Y; Aizimuaji Z; Ma S; Xiao T
Dis Markers; 2022; 2022():3317315. PubMed ID: 35968505
[TBL] [Abstract][Full Text] [Related]
26. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production.
Naugler WE; Sakurai T; Kim S; Maeda S; Kim K; Elsharkawy AM; Karin M
Science; 2007 Jul; 317(5834):121-4. PubMed ID: 17615358
[TBL] [Abstract][Full Text] [Related]
27. HDAC3 Deficiency Promotes Liver Cancer through a Defect in H3K9ac/H3K9me3 Transition.
Ji H; Zhou Y; Zhuang X; Zhu Y; Wu Z; Lu Y; Li S; Zeng Y; Lu QR; Huo Y; Shi Y; Bu H
Cancer Res; 2019 Jul; 79(14):3676-3688. PubMed ID: 31097476
[TBL] [Abstract][Full Text] [Related]
28. Smad7 regulates compensatory hepatocyte proliferation in damaged mouse liver and positively relates to better clinical outcome in human hepatocellular carcinoma.
Feng T; Dzieran J; Gu X; Marhenke S; Vogel A; Machida K; Weiss TS; Ruemmele P; Kollmar O; Hoffmann P; Grässer F; Allgayer H; Fabian J; Weng HL; Teufel A; Maass T; Meyer C; Lehmann U; Zhu C; Mertens PR; Gao CF; Dooley S; Meindl-Beinker NM
Clin Sci (Lond); 2015 Jun; 128(11):761-74. PubMed ID: 25602745
[TBL] [Abstract][Full Text] [Related]
29. Atypical inflammatory kinase IKBKE phosphorylates and inactivates FoxA1 to promote liver tumorigenesis.
Gao B; Wu X; Bu L; Jiang Q; Wang L; Liu H; Zhang X; Wu Y; Li X; Li J; Liang Y; Xu L; Xie W; Guo J
Sci Adv; 2024 Feb; 10(6):eadk2285. PubMed ID: 38324694
[TBL] [Abstract][Full Text] [Related]
30. IL-23 production of liver inflammatory macrophages to damaged hepatocytes promotes hepatocellular carcinoma development after chronic hepatitis B virus infection.
Zang M; Li Y; He H; Ding H; Chen K; Du J; Chen T; Wu Z; Liu H; Wang D; Cai J; Qu C
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3759-3770. PubMed ID: 30292634
[TBL] [Abstract][Full Text] [Related]
31. The contribution of toll-like receptor signaling to the development of liver fibrosis and cancer in hepatocyte-specific TAK1-deleted mice.
Song IJ; Yang YM; Inokuchi-Shimizu S; Roh YS; Yang L; Seki E
Int J Cancer; 2018 Jan; 142(1):81-91. PubMed ID: 28875549
[TBL] [Abstract][Full Text] [Related]
32. FOXA1 can be modulated by HDAC3 in the progression of epithelial ovarian carcinoma.
Lou T; Liu C; Qu H; Zhang Z; Wang S; Zhuang H
J Transl Med; 2022 Jan; 20(1):19. PubMed ID: 34991620
[TBL] [Abstract][Full Text] [Related]
33. Oestrogen attenuates tumour progression in hepatocellular carcinoma.
Xu H; Wei Y; Zhang Y; Xu Y; Li F; Liu J; Zhang W; Han X; Tan R; Shen P
J Pathol; 2012 Oct; 228(2):216-29. PubMed ID: 22374713
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6.
Yamaguchi N; Nakayama Y; Yamaguchi N
J Biol Chem; 2017 May; 292(20):8136-8148. PubMed ID: 28270510
[TBL] [Abstract][Full Text] [Related]
35. Deletion of HNF1α in hepatocytes results in fatty liver-related hepatocellular carcinoma in mice.
Ni Q; Ding K; Wang KQ; He J; Yin C; Shi J; Zhang X; Xie WF; Shi YQ
FEBS Lett; 2017 Jul; 591(13):1947-1957. PubMed ID: 28547778
[TBL] [Abstract][Full Text] [Related]
36. Context-specific roles of diphthamide deficiency in hepatocellular carcinogenesis.
Tu WL; Chih YC; Shih YT; Yu YR; You LR; Chen CM
J Pathol; 2022 Oct; 258(2):149-163. PubMed ID: 35781884
[TBL] [Abstract][Full Text] [Related]
37. Elevated expression of Erbin destabilizes ERα protein and promotes tumorigenesis in hepatocellular carcinoma.
Wu H; Yao S; Zhang S; Wang JR; Guo PD; Li XM; Gan WJ; Mei L; Gao TM; Li JM
J Hepatol; 2017 Jun; 66(6):1193-1204. PubMed ID: 28192186
[TBL] [Abstract][Full Text] [Related]
38. Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice.
Lin H; Yan J; Wang Z; Hua F; Yu J; Sun W; Li K; Liu H; Yang H; Lv Q; Xue J; Hu ZW
Hepatology; 2013 Jan; 57(1):171-82. PubMed ID: 22859216
[TBL] [Abstract][Full Text] [Related]
39. SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of SOCS1 and downregulation of p65 in hepatocellular carcinoma.
Lin L; Chen S; Wang H; Gao B; Kallakury B; Bhuvaneshwar K; Cahn K; Gusev Y; Wang X; Wu Y; Marshall JL; Zhi X; He AR
Theranostics; 2021; 11(9):4232-4250. PubMed ID: 33754058
[No Abstract] [Full Text] [Related]
40. Male-specific hepatitis B virus large surface protein variant W4P potentiates tumorigenicity and induces gender disparity.
Lee SA; Kim H; Won YS; Seok SH; Na Y; Shin HB; Inn KS; Kim BJ
Mol Cancer; 2015 Feb; 14(1):23. PubMed ID: 25645622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]